X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

By Nicole Longo  |    May 22, 2017
We often discuss the creation of Part D when we talk about the market-based changes that the Medicare Modernization Act (MMA) made to Medicare, but that’s just one example. Today, let’s take a...   Read More

Medicare Monday: Stakeholders raise concern with MedPAC’s proposed changes to drug purchasing program

By Nicole Longo  |    April 24, 2017
A couple weeks ago, we looked at what a broad group of stakeholders have said about the recommended changes to Part B that the Medicare Payment Advisory Commission (MedPAC) voted in support of....   Read More

Medicare Monday: What they are saying about MedPAC’s Part B recommendations

By Nicole Longo  |    April 10, 2017
Last week, the Medicare Payment Advisory Commission (MedPAC) voted on a number of recommendations affecting Medicare Part B. These proposed changes could negatively impact patients’ access to Part...   Read More

Medicare Monday: A guide to MedPAC’s Part B vote this week

By Allyson Funk  |    April 3, 2017
The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises Congress on issues related to the Medicare program, including payment, access to and quality...   Read More

Medicare Monday: Billing code basics for biologics in Part B

By Allyson Funk  |    March 20, 2017
We’ve explored the Centers for Medicare & Medicaid Services’ (CMS) flawed policy for reimbursing biologic and biosimilar products before. Today, we’re exploring how proposals from MedPAC would...   Read More

Medicare Monday: A closer look at Part B spending

By Nicole Longo  |    March 13, 2017
Earlier this month, MedPAC discussed Part B drug spending growth but neglected to put this information in the context of overall program spending. Spending on Part B medicines continues to be a...   Read More

Medicare Monday: How Medicare helps beneficiaries access needed medicines

By Nicole Longo  |    January 23, 2017
Throughout 2016, we looked at how different groups of beneficiaries – from seniors to minority communities to individuals with lower-incomes – rely on Medicare to access their needed prescription...   Read More

Medicare Monday: A closer look at Medicare Part B

By Kelsey Lang  |    January 16, 2017
We took a deeper dive on Medicare Part D last week, so today we’re switching gears and talking about Medicare Part B.   Read More

Medicare Monday: Kicking off 2017 with Medicare resources

By Nicole Longo  |    January 2, 2017
Happy New Year, #MedicareMonday readers!   Read More

Medicare Monday: New research finds trends in Average Sales Price of Part B drugs remains stable

By Kelsey Lang  |    December 19, 2016
Earlier this year, we looked at Average Sales Price (ASP) and how it works in Medicare Part B. As you may remember, ASP (the method for reimbursing drugs covered by Part B) is a market-based price...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates